ARCHIVES

OMB Restrictions On Reprogramming Could Result In Inefficient Last Minute Spending By Institutes

This article is from The Cancer Letter archive.

Vol. 11 No. 35 | September 13, 1985

Download PDF Visit The Full Archive

Related Articles

DCPC Advisors Okay Continuation of Children’s Diet Study

January 31, 1992

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005

In Brief: Let Salaries Rise To Legal Levels, Biomedical Panel Says; Prostatic Cancer Blood Test Found

July 9, 1976

Washington Braces For Oncologists; It’s The Spring Meetings

May 4, 1990

Masons Give $65 Million to Univ. of Minnesota Cancer Center.

April 25, 2008

Going private may allow US Oncology to restructure, respond to Medicare cuts; equity investment firm offers to purchase shares.

April 23, 2004